Lingxiao Zhang

Department of Medical Oncology, The First Affiliated Hospital of Xian Jiaotong University, Xi’an, P.R. China

Biography

Department of Medical Oncology, The First Affiliated Hospital of Xian Jiaotong University, Xi’an, P.R. China , EGFR; Erlotinib; Osimertinib; Lung adenocarcinoma; Circulating tumor DNA assay, EGFR Primary T790M and L858R Double Mutation Confers Clinical Benefit to Erlotinib and Resistance to Osimertinib in One Lung Adenocarcinoma Patient: A Case Report

Relevant Topics

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

CAS Source Index (CASSI)
Index Copernicus
Google Scholar
Sherpa Romeo
Academic Journals Database
Open J Gate
Genamics JournalSeek
Academic Keys
JournalTOCs
China National Knowledge Infrastructure (CNKI)
CiteFactor
Scimago
Ulrich's Periodicals Directory
Electronic Journals Library
RefSeek
Hamdard University
EBSCO A-Z
Directory of Abstract Indexing for Journals
World Catalogue of Scientific Journals
OCLC- WorldCat
Scholarsteer
SWB online catalog
Virtual Library of Biology (vifabio)
Publons
MIAR
University Grants Commission
Geneva Foundation for Medical Education and Research

Cancer Science & Therapy